date,title,source
Oct-17-18,Halo Labs Signs US$2 Million Per Month Extraction Agreement with Falcon International to Supply Cannabis Oil in California,Business Wire
Oct-17-18,"Market Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Technologies, and Capricor Therapeutics  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Oct-22-18,Halozyme Provides Summary Results Of Data For PEGPH20 Combination Treatments Presented At ESMO 2018 Congress,PR Newswire
Oct-23-18,Halo Labs Inc. Opens NEO,Business Wire
Oct-26-18,Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Exelixis,ACCESSWIRE
Nov-01-18,Halo Labs Announces Launch of Edibles in Oregon,Business Wire
Nov-06-18,"Halozyme Therapeutics (HALO) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-06-18,Halozyme Therapeutics: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Halozyme Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-06-18,A Preview Of Halozyme Therapeutics Q3 Earnings,Benzinga
Nov-06-18,Halozyme Names Albert Kildani As Vice President Investor Relations And Corporate Communications,PR Newswire
Nov-08-18,"Report: Exploring Fundamental Drivers Behind Entergy, BLACKLINE INC, HollyFrontier, Hill-Rom, Apache, and Halozyme Therapeutics  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-09-18,Halo Labs Announces Dispensary Sales for the Month of October,Business Wire
Nov-14-18,Halozyme Therapeutics Sees Hammer Chart Pattern: Time to Buy?,Zacks
Nov-16-18,Today's Research Reports on Trending Tickers: Loxo Oncology and Halozyme Therapeutics,ACCESSWIRE
Nov-19-18,Edited Transcript of HALO earnings conference call or presentation 6-Nov-18 9:30pm GMT,Thomson Reuters StreetEvents
Nov-26-18,Halozyme Announces Change In Primary Endpoint For HALO-301 To Overall Survival,PR Newswire
Nov-27-18,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",Benzinga
Nov-27-18,Today's Research Reports on Trending Tickers: Halozyme Therapeutics and Loxo Oncology,ACCESSWIRE
Nov-29-18,"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO",PR Newswire
Nov-29-18,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Halozyme Therapeutics, Inc. (HALO)",GlobeNewswire
Nov-29-18,What You Must Know About Halozyme Therapeutics Incs (NASDAQ:HALO) Financial Strength,Simply Wall St.
